AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20067641 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus coagulans GBI‐30, 6086
Number of subjects: 45
Study 20067641 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 17469680 — intervention group
Group type: EXPERIMENTAL
Intervention: New drug (not specified)
Number of subjects: 0
Study 17469680 — intervention group
Group type: COMPARATOR
Intervention: Standard agent (not specified)
Number of subjects: 0
Study 17469680 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16096515 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 20
Study 16096515 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 12324797 — intervention group
Group type: EXPERIMENTAL
Intervention: LMSRT
Number of subjects: 14
Study 12324797 — intervention group
Group type: EXPERIMENTAL
Intervention: FRIACOM
Number of subjects: 14
Study 10414756 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity step aerobics training (50% of peak oxygen uptake) for 12 weeks, progressing to 100 minutes per week of step aerobics and 50 minutes per week of cycling
Number of subjects: 26
Study 10414756 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training program)
Number of subjects: 26
Study 7594425 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin (5 mg/kg twice a day)
Number of subjects: 0
Study 7594425 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2064591 — intervention group
Group type: EXPERIMENTAL
Intervention: Local hyperthermia in addition to radical radiation (Group II)
Number of subjects: 50
Study 2064591 — intervention group
Group type: COMPARATOR
Intervention: Radical radiation only (Group I)
Number of subjects: 50
Study 6195240 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g latamoxef
Number of subjects: 236
Study 6195240 — intervention group
Group type: COMPARATOR
Intervention: 1 g cephaloridine
Number of subjects: 236
Study 31865134 — intervention group
Group type: EXPERIMENTAL
Intervention: Early AED withdrawal (discontinued at one year post-surgery)
Number of subjects: 135
Study 31865134 — intervention group
Group type: COMPARATOR
Intervention: Late AED withdrawal (continued on single AED for three years before discontinuation)
Number of subjects: 135
Study 31865134 — intervention group
Group type: EXPERIMENTAL
Intervention: Early AED withdrawal
Number of subjects: 135
Study 31865134 — intervention group
Group type: COMPARATOR
Intervention: Late AED withdrawal
Number of subjects: 135
Study 31865134 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 135
Study 31292457 — intervention group
Group type: EXPERIMENTAL
Intervention: liraglutide
Number of subjects: 50
Study 31292457 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 50
Study 29977328 — intervention group
Group type: EXPERIMENTAL
Intervention: Open abdomen (OA) management with application of an active negative peritoneal pressure therapy (ANPPT) dressing
Number of subjects: 0
Study 29977328 — intervention group
Group type: COMPARATOR
Intervention: Formal closure of the fascia
Number of subjects: 0
Study 26884588 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) with cisplatin, paclitaxel, cetuximab ± everolimus
Number of subjects: 94
Study 25139226 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal dressing group (PDG)
Number of subjects: 36
Study 25139226 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG, non-placement of periodontal dressing)
Number of subjects: 36
Study 25139226 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study 22951888 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 2993
Study 22951888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2993
Study 22951888 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 2993
Study 19651582 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular procedural skills curriculum for pediatric residents during intern orientation
Number of subjects: 38
Study 19651582 — intervention group
Group type: COMPARATOR
Intervention: Usual methods of learning procedural skills (Control)
Number of subjects: 38
Study 19651582 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular procedural skills curriculum for pediatric residents
Number of subjects: 38
Study 17497548 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 30
Study 17497548 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only
Number of subjects: 30
Study 16320677 — intervention group
Group type: EXPERIMENTAL
Intervention: Emoxipine
Number of subjects: 120
Study 16320677 — intervention group
Group type: EXPERIMENTAL
Intervention: Reamberin
Number of subjects: 120
Study 16320677 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexidol
Number of subjects: 120
Study 16320677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 12081777 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Thiersch‐Duplay urethroplasty (group A)
Number of subjects: 381
Study 12081777 — intervention group
Group type: COMPARATOR
Intervention: Parameatal based flip‐flap Mathieu hypospadias repair (group B)
Number of subjects: 381
Study 12081777 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 381
Study 9854662 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Controlled Analgesia (PCA) regimen
Number of subjects: 60
Study 9854662 — intervention group
Group type: COMPARATOR
Intervention: Standard analgesic regimen
Number of subjects: 60
Study 7611214 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa-n3 therapy
Number of subjects: 1
Study 7611214 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet transfusion, intravenous steroids, and intravenous immunoglobulin
Number of subjects: 1
Study 2225703 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg every 6 hours
Number of subjects: 10
Study 2225703 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 7000219 — intervention group
Group type: EXPERIMENTAL
Intervention: iotroxamide
Number of subjects: 200
Study 7000219 — intervention group
Group type: COMPARATOR
Intervention: iogylcamide
Number of subjects: 200
Study 31332665 — intervention group
Group type: EXPERIMENTAL
Intervention: Core needle biopsy (CNB) diagnosed atypical papillary neoplasms (PN)
Number of subjects: 317
Study 31332665 — intervention group
Group type: EXPERIMENTAL
Intervention: Core needle biopsy (CNB) diagnosed papillary neoplasms (PN) with concurrent atypical ductal hyperplasia
Number of subjects: 317
Study 31332665 — intervention group
Group type: EXPERIMENTAL
Intervention: Core needle biopsy (CNB) diagnosed papillary neoplasms (PN) with concurrent atypical lobular hyperplasia/flat epithelial atypia
Number of subjects: 317
Study 31332665 — intervention group
Group type: EXPERIMENTAL
Intervention: Core needle biopsy (CNB) diagnosed non-atypical papillary neoplasms (PN)
Number of subjects: 317
Study 27960614 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term individual shear rate therapy (ISRT)
Number of subjects: 14
Study 27960614 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term individual shear rate therapy (ISRT)
Number of subjects: 14
Study 26183582 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual music therapy
Number of subjects: 17
Study 26183582 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 17
Study 23383603 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreatin 25,000 minimicrospheres (Creon 25000 MMS); 9-15 capsules/day (3 with main meals, 2 with snacks)
Number of subjects: 58
Study 23383603 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 23383603 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreatin 25,000 minimicrospheres (Creon 25000 MMS) during open-label extension
Number of subjects: 58
Study 23383603 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreatin 25,000 minimicrospheres (Creon 25000 MMS)
Number of subjects: 58
Study 21879368 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeless adults
Number of subjects: 247
Study 19249017 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT) delivered in addition to treatment-as-usual (TAU)
Number of subjects: 28
Study 19249017 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU) alone
Number of subjects: 28
Study 17310045 — intervention group
Group type: COMPARATOR
Intervention: tiotropium plus placebo
Number of subjects: 449
Study 17310045 — intervention group
Group type: COMPARATOR
Intervention: tiotropium plus salmeterol
Number of subjects: 449
Study 17310045 — intervention group
Group type: COMPARATOR
Intervention: tiotropium plus fluticasone-salmeterol
Number of subjects: 449
Study 15204372 — intervention group
Group type: EXPERIMENTAL
Intervention: Bell-and-pad (alarm) system for 12 weeks
Number of subjects: 28
Study 11261404 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced negative mood
Number of subjects: 0
Study 11261404 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulating the stop rules for catastrophizing
Number of subjects: 0
Study 11261404 — intervention group
Group type: EXPERIMENTAL
Intervention: Mood as input hypothesis
Number of subjects: 0
Study 9586892 — intervention group
Group type: EXPERIMENTAL
Intervention: 17-1A antibody (900 mg total: 500 mg postoperatively followed by 4 monthly doses of 100 mg)
Number of subjects: 189
Study 9586892 — intervention group
Group type: COMPARATOR
Intervention: Observation only
Number of subjects: 189
Study 7988180 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (bolus, 0.25 mg; maintenance dose, 5 micrograms/min)
Number of subjects: 10
Study 7988180 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 3054048 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Widman flap combined with citric acid demineralization and autologous fibronectin application
Number of subjects: 29
Study 3054048 — intervention group
Group type: COMPARATOR
Intervention: Modified Widman flap alone
Number of subjects: 29
Study 4925508 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% N-acetylcysteine plus isoproterenol
Number of subjects: 12
Study 4925508 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% 2-mercaptoethane sulphonate plus isoproterenol
Number of subjects: 12
Study 4925508 — intervention group
Group type: COMPARATOR
Intervention: Control aerosol of saline
Number of subjects: 12
Study 4925508 — intervention group
Group type: COMPARATOR
Intervention: Control aerosol of saline plus isoproterenol
Number of subjects: 12
Study 31645423 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin-paclitaxel plus bevacizumab (control arm)
Number of subjects: 404
Study 31645423 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin-paclitaxel plus bevacizumab plus atezolizumab (experimental arm)
Number of subjects: 404
Study 30979632 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolyzed rice-protein formulas (HRPFs)
Number of subjects: 0
Study 28294936 — intervention group
Group type: EXPERIMENTAL
Intervention: Serve at least two vegetables with dinner meals
Number of subjects: 39
Study 28294936 — intervention group
Group type: COMPARATOR
Intervention: Pair vegetables with other foods the child likes
Number of subjects: 39
Study 28294936 — intervention group
Group type: COMPARATOR
Intervention: Eat dinner together with an adult(s) modelling vegetable consumption
Number of subjects: 39
Study 25196580 — intervention group
Group type: EXPERIMENTAL
Intervention: Pumpkin seed (5 g b.i.d.)
Number of subjects: 1431
Study 25196580 — intervention group
Group type: EXPERIMENTAL
Intervention: Pumpkin seed extract (500 mg b.i.d.)
Number of subjects: 1431
Study 25196580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1431
Study 23333088 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFA (2.090 g of EPA and 1.165 g of DHA)
Number of subjects: 109
Study 23333088 — intervention group
Group type: COMPARATOR
Intervention: High-oleic-acid sunflower oil (placebo)
Number of subjects: 109
Study 21274882 — intervention group
Group type: EXPERIMENTAL
Intervention: rcHIP/PAP
Number of subjects: 100
Study 18463627 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg infused over 30 min)
Number of subjects: 8
Study 18463627 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 8
Study 16581488 — intervention group
Group type: EXPERIMENTAL
Intervention: On-pump operation (cardiopulmonary bypass)
Number of subjects: 18
Study 16581488 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump operation (no cardiopulmonary bypass)
Number of subjects: 18
Study 16581488 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 18
Study 12646793 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymetholone TID (150 mg/day)
Number of subjects: 89
Study 12646793 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymetholone BID (100 mg/day)
Number of subjects: 89
Study 12646793 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 10646814 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH‐a/hMG
Number of subjects: 161
Study 10646814 — intervention group
Group type: COMPARATOR
Intervention: hMG only
Number of subjects: 161
Study 10646814 — intervention group
Group type: EXPERIMENTAL
Intervention: One AIH
Number of subjects: 161
Study 10646814 — intervention group
Group type: COMPARATOR
Intervention: Two AIHs
Number of subjects: 161
Study 9346145 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral principles on a pain management program (group therapy)
Number of subjects: 84
Study 9346145 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral principles on a pain management program (individual therapy)
Number of subjects: 84
Study 9346145 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral principles on a pain management program (15-hour program)
Number of subjects: 84
Study 9346145 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral principles on a pain management program (30-hour program)
Number of subjects: 84
Study 9346145 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral principles on a pain management program (60-hour program)
Number of subjects: 84
Study 8445454 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed plasma fibronectin levels
Number of subjects: 17
Study 3524463 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy plus immunotherapy with N-CWS and irradiated allogeneic AML cells
Number of subjects: 73
Study 3524463 — intervention group
Group type: COMPARATOR
Intervention: Maintenance chemotherapy
Number of subjects: 73
Study 28691316 — intervention group
Group type: EXPERIMENTAL
Intervention: Unwaxed dental floss impregnated with 2% chlorhexidine (used twice daily)
Number of subjects: 30
Study 28691316 — intervention group
Group type: COMPARATOR
Intervention: Standard unwaxed dental floss (used twice daily)
Number of subjects: 30
Study 28691316 — intervention group
Group type: COMPARATOR
Intervention: Negative control (no interproximal cleaning)
Number of subjects: 30
Study 27409603 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarcosine (2 grams daily)
Number of subjects: 58
Study 27409603 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 27429285 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT PICO™ dressing)
Number of subjects: 92
Study 27429285 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Comfeel Plus(®) dressing)
Number of subjects: 92
Study 22828288 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated PCST and exercise program delivered by physiotherapists
Number of subjects: 3
Study 22828288 — intervention group
Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 3
Study 22828288 — intervention group
Group type: COMPARATOR
Intervention: PCST alone
Number of subjects: 3
Study 20428367 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunflower seed oil (SSO)
Number of subjects: 0
Study 20428367 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquaphor
Number of subjects: 0
Study 20428367 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 0
Study 18686773 — intervention group
Group type: EXPERIMENTAL
Intervention: Stannous fluoride/sodium hexametaphosphate dentifrice
Number of subjects: 16
Study 18686773 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetylpyridinium chloride mouthrinse with stannous fluoride dentifrice
Number of subjects: 16
Study 18686773 — intervention group
Group type: COMPARATOR
Intervention: Sodium fluoride triclosan/copolymer dentifrice
Number of subjects: 16
Study 18686773 — intervention group
Group type: COMPARATOR
Intervention: Essential oil mouthrinse with triclosan dentifrice
Number of subjects: 16
Study 16572647 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery with neuronavigation (SN)
Number of subjects: 45
Study 16572647 — intervention group
Group type: COMPARATOR
Intervention: Standard surgery (SS)
Number of subjects: 45
Study 12960179 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (ACZ) injection
Number of subjects: 16
Study 10687883 — intervention group
Group type: EXPERIMENTAL
Intervention: Menorest (50 microg/24 h)
Number of subjects: 20
Study 10687883 — intervention group
Group type: COMPARATOR
Intervention: Climara (50 microg/24 h)
Number of subjects: 20
Study 9431499 — intervention group
Group type: EXPERIMENTAL
Intervention: Written condition (transcription of pediatrician's instructions)
Number of subjects: 96
Study 9431499 — intervention group
Group type: COMPARATOR
Intervention: Oral condition (verbal instruction only)
Number of subjects: 96
Study 10135639 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive statistical package (ISP) using pretreatment clinical factors (PSA, Gleason score, clinical stage, MRI findings)
Number of subjects: 174
Study 10135639 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive statistical package (ISP)
Number of subjects: 174
Study 3531113 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of misonidazole (2.0 gm/m2) and hyperbaric oxygen (3 ATA) with irradiation (6.0 Gy in 30 fractions)
Number of subjects: 130
Study 3531113 — intervention group
Group type: COMPARATOR
Intervention: Conventional irradiation (63.00 Gy in 30 fractions)
Number of subjects: 130
Study 31097299 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-week trunk-specific rehabilitation program (active self-correction exercises, passive and active trunk stabilization exercises, functional tasks)
Number of subjects: 37
Study 31097299 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-week trunk-specific rehabilitation program
Number of subjects: 37
Study 31097299 — intervention group
Group type: COMPARATOR
Intervention: Control group (joint mobilization, muscle strengthening and stretching, gait and balance exercises)
Number of subjects: 37
Study 29603684 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemafibrate (0.4 mg/day, b.i.d.)
Number of subjects: 27
Study 29603684 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 29603684 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemafibrate
Number of subjects: 27
Study 26735225 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine 150 mg once daily for 8 weeks
Number of subjects: 0
Study 26735225 — intervention group
Group type: COMPARATOR
Intervention: Placebo once daily for 8 weeks
Number of subjects: 0
Study 24698346 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinol (7.5 mg RE/d)
Number of subjects: 998
Study 24698346 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene (30 mg/d)
Number of subjects: 998
Study 23227789 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture coupled with conventional treatments
Number of subjects: 30
Study 23227789 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatments alone
Number of subjects: 30
Study 20682023 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling on diet, physical activity, and gestational weight gain during pregnancy (one session at 8-12 weeks for physical activity, one session at 16-18 weeks for diet, and three to four booster sessions during routine visits)
Number of subjects: 14
Study 20682023 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 14
Study 20682023 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling on diet and physical activity
Number of subjects: 14
Study 20682023 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood samples for lipid status, hormones, insulin, and OGTT
Number of subjects: 14
Study 20682023 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire on workability and return to work
Number of subjects: 14
Study 17638703 — intervention group
Group type: EXPERIMENTAL
Intervention: IPTi with sulfadoxine‐pyrimethamine
Number of subjects: 1200
Study 17638703 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1200
Study 15450784 — intervention group
Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) levels in RBC
Number of subjects: 200
Study 15450784 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of EPA in RBC
Number of subjects: 200
Study 11251010 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐FU plus leucovorin (arm A)
Number of subjects: 680
Study 11251010 — intervention group
Group type: COMPARATOR
Intervention: 5‐FU plus levamisole (arm B)
Number of subjects: 680
Study 9606226 — intervention group
Group type: EXPERIMENTAL
Intervention: Case management/home visitation intervention with at least four home visits during the infant's first year of life
Number of subjects: 365
Study 9606226 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 365
Study 9606226 — intervention group
Group type: EXPERIMENTAL
Intervention: Case management/home visitation intervention
Number of subjects: 365
Study 8014723 — intervention group
Group type: EXPERIMENTAL
Intervention: ACI-TIPI intervention during experimental months
Number of subjects: 418
Study 8014723 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ACI-TIPI provided during control months)
Number of subjects: 418
Study 2499185 — intervention group
Group type: EXPERIMENTAL
Intervention: Water (0 mOsm/kg)
Number of subjects: 10
Study 2499185 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol solution (142 mOsm/kg)
Number of subjects: 10